Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome

Internal Medicine

Volumn 40, Issue 11, 2001, Pages 1158-1161

  Masuda, A ^a   Nakayama, T ^a   Yamanaka, T ^a   Hatsutanmaru, K ^a   Tei, C ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Combination therapy; Cytomegalovirus infection; Natural killer cell activity; Serum acylcarnitine

Indexed keywords

ACYLCARNITINE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; DIET RESTRICTION; DISEASE EXACERBATION; HUMAN; MALE; MENTAL DISEASE; NATURAL KILLER CELL; PHYSICAL DISEASE; REHABILITATION; SYMPTOM;

EID: 0035213306     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.1158     Document Type: Article

References (25)

1. Prognosis in chronic fatigue syndrome: A prospective study on the natural course
2. The treatment of chronic fatigue syndrome: Science and Speculation
3. Cognitive behavioral therapy in chronic fatigue syndrome
4. Psychophysiological study on fasting therapy
5. The Cornell Medical Index-Health questionnarie III. The evaluation of emotional disturbances
6. Chronic fatigue syndrome: A working case definition
7. Studies of herpesvirus infection in chronic fatigue syndrome. Chronic fatigue syndrome
8. Sporadic postinfectious neuromyastenia
9. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human man herpesvirus type 6 infection
10. Postinfectious chronic fatigue syndrome: Case history of thirty-five patients in Germany
11. Chronic fatigue: A prospective clinical and virologic study
12. A comprehensive immunological analysis in chronic fatigue syndrome
13. Life change stress, psychiatric symptoms, and natural killer cell activity
14. Life events, depressive symptoms, and immune function
15. Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome
16. Activation of human NKCC by moderate exercise: Increased frequency of NK cells with enhanced capability of effector-target lytic interactions
17. Acylcarnitine deficiency in chronic fatigue syndrome
18. Carnitine metabolism and human nutrition
19. Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine
20. Acylcarnitine metabolism during fasting and after refeeding
21. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
22. Evidence for impaired activation of hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
23. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trail
24. Effect of experimental and pathological weight loss upon the hypothalamo-pituitary-adrenal axis
25. Fasting therapy for psychosomatic diseases with special reference to its indication and therapeutic mechanism